Curated for Orthogate.org Members

CLINICAL OVERVIEW

Stryker Corporation has announced the full commercial introduction and FDA 510(k) clearance of the Sonopet® 3 Ultrasonic Tissue Removal System, representing the latest generation of its ultrasonic bone cutting and soft-tissue cavitation technology. Designed for complex spine, neurosurgical, and orthopaedic oncology applications, the system couples high-frequency acoustic wave generation with simultaneous irrigation and vacuum aspiration. Driven by high-efficiency piezoelectric transducers oscillating at 25 kHz to 34 kHz, the console converts electrical energy into longitudinal and torsional micro-vibrations at the working tip. This biomechanical modality relies on differential acoustic impedance: rigid mineralized cortical bone is rapidly fragmented and sheared, while viscoelastic neural structures (dura mater, spinal cord, and nerve roots) and vascular adventitia deflect the acoustic waves, providing an elevated safety margin during aggressive bony decompression.

At the center of the Sonopet® 3 advancement is the introduction of proprietary Pulse Control technology, engineered through extensive multi-center clinical feedback from hundreds of spine and neurosurgical attendings. Pulse Control provides calibrated duty-cycle micro-burst energy modulation, granting operative teams granular authority over acoustic cavitation kinetics. Surgeons can alternate between high-power continuous bone decortication during canal decompression or facetectomy, and pulsed, lower-impact soft-tissue emulsification when mobilizing adherent epidural scar tissue or debulking intra- and extradural neoplasms. The platform also debuts Stryker's RISE (Reimagined Integrated Surgical Experience) console architecture, which features an intuitive touchscreen interface, automated RFID smart-handpiece identification with preloaded surgeon profiles, and closed-loop irrigation synchronization to eliminate dry tip cavitation and collateral thermal osteonecrosis.

In orthopaedic spine and musculoskeletal oncologic surgery, Sonopet® 3 directly mitigates the clinical hazards inherent to conventional high-speed rotating pneumatic or electric burrs. Rotating burrs generate tangential kinetic torque that is prone to "kickback" or "skiving," while posing an acute danger of catching and wrapping adjacent cottonoids, neuropatties, or dural sleeves. Furthermore, mechanical burrs create significant bone dust and friction that require constant manual suction-irrigation by an assistant. Sonopet® 3 eliminates rotational torque entirely, clears bone particulate instantly via coaxial suction-irrigation, and delivers a pristine, bloodless operative corridor under high magnification without obscuring micro-anatomical margins.

REGULATORY & EVIDENCE PATHWAY

• Regulatory Basis: U.S. Food and Drug Administration (FDA) 510(k) clearance granted in October 2026 under 21 CFR 878.4400 (Electrosurgical cutting and coagulation device and accessories / Instrument, Ultrasonic Surgical; Product Code: LFL), establishing substantial equivalence in acoustic ablation, bone resection, and thermal safety profiles to predicate Sonopet® and Sonopet® iQ systems.
• Supporting Evidence: Multicenter bench validation and acoustic thermography trials demonstrated sub-millimeter thermal margin containment (<1.0 mm) across continuous cutting cycles. Decades of cumulative clinical literature evaluating ultrasonic bone curettes in spinal decompression corroborate a significant decrease in accidental durotomies—reducing incisional dural tears from 5% to 10% with conventional rotating burrs down to <1.5% with ultrasonic instrumentation in high-risk thoracic ossification of the posterior longitudinal ligament (OPLL) and revision decompression cohorts.
• Key Data Points: Bench evaluation of the integrated Pulse Control architecture demonstrated up to a 20% increase in cutting efficiency through dense cortical bone compared to standard continuous ultrasonic modes, coupled with an ergonomic redesign of the handpiece assembly that reduces surgeon hand-grip fatigue by over 25% during prolonged multi-hour deformity and oncologic resections.

SURGICAL WORKFLOW IMPACT

Operative setup and execution benefit from the unified RISE console and smart-connect cables, enabling operating room teams to set up and calibrate sterile handpieces in under two minutes without manual console tuning. The integrated coaxial suction and irrigation lines eliminate the need for an assistant to hold separate suction tips or squirt bulb irrigation, decluttering the operative corridor under high-magnification surgical loupes or operating microscopes.

The absence of spinning rotational shafts removes the risk of entanglement with surgical sponges, cottonoid patties, or dural margins, allowing attendings to operate in tight, constrained corridors such as thoracic transpedicular approaches, minimally invasive tubular decompressions, or anterior odontoid resections. The intuitive foot-pedal interface enables seamless modulation of aspiration, irrigation, and Pulse Control power on the fly without breaking microscopic focus.

COMPETITIVE LANDSCAPE

The Sonopet® 3 platform competes in the advanced surgical dissection sector against Integra LifeSciences' CUSA® Clarity ultrasonic surgical aspirator, the Misonix / DePuy Synthes BoneScalpel® ultrasonic bone cutter, and Söring ultrasonic systems.

While dedicated ultrasonic bone cutters (such as BoneScalpel®) excel exclusively in osteotomies but lack versatility in soft tissue debulking, and traditional neurosurgical aspirators (such as older CUSA® platforms) focus primarily on soft parenchymal tumors, Sonopet® 3 bridges both domains through longitudinal-torsional (LT) tip dynamics. This dual capability allows a spine or oncology surgeon to complete a dense cortical uncinate or facet resection, switch tips or adjust Pulse Control settings, and immediately proceed to epidural tumor debulking or fibrous scar release using a single console, eliminating the capital expense and OR clutter of multiple energy platforms.

CLINICAL SIGNIFICANCE FOR ORTHOGATE MEMBERS

For spine surgeons, orthopaedic oncologists, and complex reconstructive attendings, Sonopet® 3 represents an invaluable precision tool for high-stakes bone-neural interfaces. In pathologies characterized by severe compression and absent epidural fat planes—such as thoracic OPLL, calcified herniated thoracic discs, cervical spondylotic myelopathy, and sacral chordomas—the system provides an indispensable margin of surgical safety. The eradication of rotational torque prevents catastrophic kickback into the dural sac, while Pulse Control empowers surgeons to sculpt bone down to an eggshell transparency before elevating it off the underlying nervous tissue, optimizing procedural speed and neurological preservation.

Sources:

• OrthoSpineNews: Stryker Launches Sonopet® 3 Ultrasonic Tissue Removal System
• Stryker Corporation — Official Ultrasonic Surgical Solutions Portal
• U.S. FDA 510(k) Premarket Notification Database